Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rotarix
Manufacturing
GSK's rotavirus shot runs short due to manufacturing issues
GSK faces an "unplanned, short-term drop in Rotarix production for 2022," thanks to unspecified "manufacturing challenges," the company told Fierce.
Fraiser Kansteiner
Aug 11, 2022 4:00pm
Serum Institute touts phase 3 rotavirus data, preps deliveries
Sep 26, 2017 7:27pm
FiercePharmaAsia—WuXi AppTec, Shionogi and Purdue, EMA
Mar 31, 2017 8:46am
Serum’s heat-stable rotavirus vaccine shines in phase 3
Mar 28, 2017 2:07pm